Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
The clinical decision support system is a significant tool which provides information to the care Team. The care team is comprised of the clinician, nurses, patients care giver, administrative-staff and other members. The extracted information then separated by the different person and situations. Clinical decision support system is framed for improve quality, minimize the adverse effects, and also helps in efficiency of care team. The clinical decision support system is more significant as the data volume is increasing for the healthcare providers. The clinical decision support system has wide applications in pre-diagnosis, post-diagnosis and at the time of diagnosis as it aids in taking critical decisions.
The clinical decision support system is projecting fastest growth since decades. The major influencing factors like implementation of government regulations and initiatives to promote adoption of HIT solutions, increasing adoption of CDSS-enabled EHRs, growing incidences of medication errors are propelling the market growth. However, the factors like data security concerns related to cloud based CDSS, lack of interoperability are hindering the market growth.
The exclusive COVID-19 impact analysis report by axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the clinical decision support system market. In addition, complete analysis of changes on clinical decision support system expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The COVID-19 has the made somewhat impact on every industry but the healthcare industry is mainly affected by the COVID-19 pandemics. The COVID-19 has made massive pressure on the healthcare facilities. The huge no of patients visiting daily to the healthcare providers. The increasing need of social distancing the clinical decision support system is experiencing high growth in the healthcare sectors. As because of that the COVID-19 has the positive impact on the clinical decision support system market.
The clinical decision support system is categorised by product, delivery mode, type, level of interactivity, component, model, applications and geography.
The various product like integrated clinical decision support system, standalone clinical decision support system is analysed in the clinical decision support system. The integrated clinical decision support systems are likely to dominate the market as they improve the quality of care by suggesting the cheaper medicine alternatives, reducing test duplications, shorten the patient stay in hospitals and decreases expenses over the time.
The delivery modes like on premise and cloud bases are comprised in the clinical decision support system. The on premise is likely to dominate the market as it provides the management to healthcare staff or by third parties and has more flexibility, reliability and security of the data.
The different types of clinical decision support systems are therapeutic, diagnostic in the clinical decision support systems. The therapeutic clinical decision support system is likely to dominate the market as they provide computerised reminders and advises regarding drug selection, dosage interactions, allergies.
Level of interactivities like active clinical decision support systems and passive clinical decision support systems in clinical decision support systems. The active clinical decision support system is likely to dominate the market as they are based on simple logic or systems based on probability. The variety of active clinical decision support systems has positive impact on the patient’s outcome.
The components like services, software, hardware is analysed in clinical decision support system market. The services are expected to lead the market as it provides the healthcare facilities by improving the medical decision for the patients. By suggesting safer and more effective medications.
The various models based on knowledge and non-knowledge are analysed in the clinical decision support systems. The knowledge bases models are likely to lead the market as they are suggesting physicians the knowledge-based decisions in case of uncertainties. In addition to that they have less chances of errors than the non-knowledge-based models.
The clinical decision support system has application like advanced clinical decision support systems and conventional clinical decision support systems. The advanced clinical decision support system is likely to dominate the market as it overcomes the drawbacks of conventional clinical decision support systems like alert fatigue, diagnosis errors, workflow disruptions that cause destructive effect on patient’s health.
The clinical decision support system market is analysed for the geographic sections like North America, Europe, Asia Pacific and rest of the world. The Asia Pacific is estimated to dominate the market during the forecast period as due to high geriatric populations, improved government regulations, high prevalence of chronic diseases. In addition to that the growing focus on major key players on the Asia Pacific economies are propelling the growth of market. Besides, the North America has the fastest growing in the market as it has high spending on the healthcare sectors.
The clinical decision support system market has the major key players like Agfa-Gevaert Group, Allscripts Healthcare Solutions Inc., Athenahealth Inc., Cerner Corporation, Change Healthcare, Elsevier BV, EPIC, IBM, Koninklijke Philips NV, Mckesson Corporation, Meditech, Siemens Healthcare, VisualDx, Wolters Kluwer Health, Zynx Health are analysed among the others.
The study comprised of the clinical decision support system market. The study analysed the different segments like product, delivery mode, type, level of interactivity, component. model, applications. It also comprised of the leading members of the segments. As the product segment is estimated to lead by the integrated clinical decision support systems as it provides the improve the quality of care by suggesting the cheaper medicine alternatives. The delivery mode segment is likely to dominate the market by on premise clinical decision support systems as they provide control on the data by the healthcare workers and the third party and has less chances data leak. The type segment is estimated to dominate the market by therapeutic clinical decision support systems as they provide the computerised reminders and advises regarding drug selection. The level of interactivity is leaded by the active clinical decision support systems as they based on the simple logic. The component segment is likely to dominate the market by services as they provide facilities to improve the decisions for patients. The knowledge-based models are expected to dominate the market in the model segment as it provides less errors than the nonknowledge-based models. The application segment is dominated by the advanced clinical decision support system as it overcomes of the errors of conventional clinical decision support systems. The study also imparts the geographical part of the market and it concludes that the Asia Pacific is estimated to dominate the market during the forecast period as due to high geriatric populations, improved government regulations. The study also covers the COVID-19 impact on the clinical decision support system market. The COVID-19 has the made somewhat impact on every industry but the healthcare industry is mainly affected by the COVID-19 pandemics. The COVID-19 has made massive pressure on the healthcare facilities. The huge no of patients visiting daily to the healthcare providers. The increasing need of social distancing the clinical decision support system is experiencing high growth in the healthcare sectors. As because of that the COVID-19 has the positive impact on the clinical decision support system market. In addition to that it also comprised of the major key players operating in the regions.
Why to buy this report:
